Irrespective of the share price in the next couple of days one thing is for sure - the FDA approval (hopefully successful) will take Respiri to another level!!
The sheer magnitude of opportunities to sell wheezo (with FDA approval) will be immense and our Board and Management decisions in the next couple of quarters will decide if wheezo can have a real impact not only in Australia but worldwide. Knowing the drive and energy our Management has, a challenge like this will vigorously contested !
Cheers
RSH Price at posting:
17.0¢ Sentiment: Buy Disclosure: Held
!
